Thyroid eye disease (TED), also known as Graves’ eye disease, usually stems from an autoimmune condition that starts when immune cells attack the thyroid gland, a tiny butterfly-shaped gland at the ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

LOS ANGELES, CA, UNITED STATES, January 22, 2026 / EINPresswire.com / — Renowned physician Dr. Raymond Douglas will be featured in an upcoming local segment of The Balancing Act ®, a nationally ...

Please provide your email address to receive an email when new articles are posted on . PCPs should work alongside specialists when treating thyroid eye disease, an expert told Healio. They may need ...

—Even long after the active phase of thyroid eye disease has subsided, a multitude of challenging quality-of-life issues may persist. Several recent studies have established that the physical ...

DEAR DR. ROACH: I had a total thyroidectomy in July 2022 for Graves’ disease. All the time leading up to this and almost all the time since, I’ve only had one short “active” period of thyroid eye ...

Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024 ...

Fibroblasts from patients with TED secrete active PAPP-A and are stimulated by proinflammatory cytokines, namely tumor necrosis factor (TNF)-α and interleukin (IL)-1β. Novel therapeutic agents may be ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The thyroid eye disease treatments market is undergoing substantial ...